Finance Watch: Scorpion Closes $162m Series B, Bringing Recent Total To $270m

$1.67bn In New VC Deals Includes Nearly $1bn In Two Days

Private Company Edition: The pre-J.P. Morgan Healthcare Conference financing news deluge during the first week of 2021 included several significant venture capital deals, including a $226m series B round for Affinivax, Ikena’s $120m series B round and an $88m series A round for Aro.

The week before the annual J.P. Morgan Healthcare Conference always includes a bevy of new financings and the week before this year’s 11-14 January meeting kept up with the tradition with $1.67bn in venture capital deals announced through 8 January.

Nearly $1bn – a total of $954.5m in new VC financings – were announced on 7 and 8 January alone...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Actithera Raises $75m To Enter Competitive FAP-Targeting Radioligand Field

09 Jul 2025

• By Andrew McConaghie

While companies such as Eli Lilly and Roche have faced setbacks to their fibroblast activation protein-targeting oncology therapies, Actithera believes its radiopharmaceuticals platform will prove more successful.

Concentra Picks Up Cargo In Latest Troubled Biotech Buyout

08 Jul 2025

• By Alaric DeArment

The Kevin Tang-led firm will pay $4.38 per share for Cargo, which laid off most of its workforce following the failure of a Phase II CAR-T trial.

Venture Funding Plummets In Q2 As Mega-Rounds Falter

08 Jul 2025

• By Mandy Jackson

Evaluate’s second quarter data show that VC rounds of $100m or more totaled $2.36bn, down from $5.25bn in Q2 of 2024. Overall, the Q2 total dropped year-over-year to $4.92bn from $7.95bn.